Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials
<b>Background/Objectives:</b> Cytomegalovirus (CMV) is widespread and mostly causes asymptomatic infections in immunocompetent hosts, but it may lead to severe and life-threatening diseases in immunocompromised individuals, such as transplant patients and congenitally infected children,...
Saved in:
| Main Authors: | Manuela Chiavarini, Anita Genga, Giorgia Maria Ricciotti, Marcello Mario D’Errico, Pamela Barbadoro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/1/85 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuron-restricted cytomegalovirus latency in the central nervous system regulated by CD4+ T-cells and IFN-γ
by: Fran Krstanović, et al.
Published: (2025-03-01) -
Human cytomegalovirus glycoprotein B genotypic distributions and viral load in symptomatic infants
by: Huijun Mu, et al.
Published: (2023-12-01) -
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01) -
Impact of congenital cytomegalovirus infection on vestibular dysfunction and hearing outcomes in a cohort of children
by: Malesci Rita, et al.
Published: (2025-05-01) -
The problem of congenital cytomegalovirus infection
by: R. A. Ivanova, et al.
Published: (2016-07-01)